𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination assay of CSF Tau, Aβ1-40 and Aβ1-42(43) as a biochemical marker of Alzheimer's disease

✍ Scribed by Mikio Shoji; Etsuro Matsubara; Mitsuyasu Kanai; Mitsunori Watanabe; Tamiko Nakamura; Yasushi Tomidokoro; Masami Shizuka; Katsumi Wakabayashi; Yukifusa Igeta; Yoshio Ikeda; Kazuyuki Mizushima; Masakuni Amari; Koji Ishiguro; Takeshi Kawarabayashi; Yasuo Harigaya; Koich Okamoto; Shunsaku Hirai

Book ID
119470012
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
167 KB
Volume
158
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Longitudinal study of cerebrospinal flui
Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan
✍ M. Kanai; E. Matsubara; K. Isoe; K. Urakami; K. Nakashima; H. Arai; H. Sasaki; K 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 919 KB

To clarify the alterations of tau, amyloid beta protein (A beta) 1-40 and A beta1-42(43) in the cerebrospinal fluid (CSF) that accompany normal aging and the progression of Alzheimer's disease (AD), CSF samples of 93 AD patients, 32 longitudinal subjects among these 93 AD patients, 33 patients with